IL4R and neoplasm: These studies also found that IL-4R peptide-tagged nanoparticles containing PTX selectively targeted IL-4R overexpressing human lung squamous carcinoma (H226) cells and tissues, resulting in significant cell death and prevention of H226 tumor growth [54].